News

A small study of donor corneal tissues has shown that positive sputum cultures prior to death are not correlated with positive graft cultures after preparation. Despite the presence of low levels of various pathogens, no growth was found in any bacteria or fungus rim cul-tures.

ONO-9054, a drug being developed for the treatment of ocular hypertension and primary open angle glaucoma, showed promising results in a small, randomized trial. Post-hoc analysis of the results showed that nearly 90% of patents who had received doses of 10 µg/mL or higher had IOP measurements of 18 mm Hg or lower following treatment.

A new presbyopia-correcting IOL has a novel optic combining two complementary diffractive technologies. Results from bench and clinical testing show it provides a full range of continuous, high-quality vision, minimizes dysphotopsias, and may be more tolerant to refractive errors than multifocal IOLs.

The FDA has approved VisionCare Ophthalmic Technologies’ Implantable Miniature Telescope (by Dr. Isaac Lipshitz) for use in patients living with bilateral end-stage age-related macular degeneration (AMD) who are age 65 or older.

Rayner Intraocular Lenses Ltd. have launched a new injector, RaySert Plus, in the United States market after receiving 510(k) clearance from the FDA.

The European Forum Against Blindness (EFAB) has revealed the results of an 11-country study-an extension to the data reported last year covering six countries-which reports on the economic impact of blindness and four leading eyesight conditions, and concluded that blindness and vision loss lead to a reduced quality of life and increased economic burden to society.

Welcome to the latest installment of “Sight Lines,” a feature in which J.C. Noreika, MD, MBA, an ophthalmologist in Medina, OH, discusses trends in ophthalmology, medicine, and health care with key leaders in their fields. In this issue, Dr. Noreika talks with U.S. Sen. Sherrod Brown (D-OH).

Although infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are a prominent concern for cataract surgeons, leading ophthalmologists discuss the pros and cons of performing universal MRSA screening to guide targeted prophylaxis.

Like you, I chose to attend medical school with the goal of helping patients who were ill and needed curing, comforting, or both. So perhaps the financial rewards of a career in medicine have made you feel slightly embarrassed and concerned that people might be resentful or jealous. Well, here’s good news: research suggests we physicians aren't so financially successful after all.